Skip to Content

Investor Update

Basel, 31 July 2008

Toll Manufacturing Agreement for the Bulk Drug Substance of Actemra, a Humanized Anti-Human IL-6 Receptor Monoclonal Antibody

Dear Investor,

Please find enclosed a press release by Chugai.